Golden
Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a venture capital firm based in Boston, founded in 2006, which invests in biotechnology startups.

Third Rock ventures provided venture capital to MyoKardia, a company which focuses on genetic heart diseases, that went public in 2015.

Timeline

October 31, 2016

Third Rock announces $616m Fund IV

People

Name
Role
Related Golden topics

Agnieszka Czechowicz

Advisor



Alice Jacobs

Employee



Chris Varma

Employee



Craig Muir

Partner, Cheif Technology Officer



Daniel Poscover

Employee



Elizabeth Kwo, MD

Employee



Emily Duff

Employee



Hana Bauguess

Employee



Ivan Hyep

Employee



Kevin Gillis

Partner, CFO



Michelle Gonzalez

Employee



Richard Cammett

Employee



Sarah Larson

Partner, Chief Human Resources Officer



Walter Kowtoniuk

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Ablexis







Afferent







Agios

























Ambys Medicines

























Cedilla Therapeutics







Celsius







Cibiem







Corvia Medical













Decibel Therapeutics







Edimer













Element Science



















Fulcrum Therapeutics







GBT







Goldfinch Bio







SHOW ALL (51)